Repligen | RGEN - Przychody Ze Sprzedaży

Cena Akcji
117.60
Dzienna Zmiana
3.54 3.10%
Miesięcznie
2.87%
Rocznie
-18.76%
Q2 Prognozy TE
115.08




Obroty Zmiana Data
Agilent USD 1.8B 63M 2025-12
Align Technology USD 1.05B 54.3M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Danaher USD 5.95B 890M 2026-03
Dentsply International USD 961M 57M 2025-12
General Electric Aerospace USD 11.6B 270M 2026-03
Henry Schein USD 3.4B 60M 2025-12
Illumina USD 1.16B 80M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pfizer USD 17.58B 880M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Standard Biotools USD 23.8M 4.24M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Waters USD 932M 132M 2025-12
West Pharmaceutical Services USD 844.9M 39.9M 2026-03